Patents for A61P 35 - Antineoplastic agents (221,099) |
---|
09/08/1991 | WO1991013907A1 Derivatives of n-phenyl glycinamide, their preparation and medicaments containing them |
09/08/1991 | CA2074375A1 N-phenyl glycinamide derivatives, preparation thereof and drugs containing same |
09/07/1991 | CA2037531A1 Preparation, which stimulates the immune system, can be applied parenterally and has a long shelf life, and method forproducing it |
09/05/1991 | WO1991013148A1 AN IgG-1 HUMAN MONOCLONAL ANTIBODY REACTIVE WITH AN HIV-1 GLYCOPROTEIN AND METHOD OF USE |
09/05/1991 | WO1991013094A1 Inhibitor of proliferation of endothelial cells |
09/05/1991 | WO1991013083A1 Steroid sulphatase inhibitors |
09/05/1991 | WO1991013060A1 Indole derivatives |
09/05/1991 | WO1991013055A2 New aryl- and heteroarylethenylene derivatives and process for their preparation |
09/05/1991 | WO1991013053A1 DERIVATIVE OF β-PHENYLISOSERINE, PREPARATION AND UTILISATION THEREOF |
09/05/1991 | WO1991011201A3 Compounds |
09/05/1991 | WO1991006866A3 Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
09/05/1991 | WO1991006314A3 Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins |
09/05/1991 | DE4005630A1 Monoclonal antibodies against tumour-associated antigens - specifically MAB BW SCLC-1 and MAB BW SCLC-2, used in immune therapy and treatment and diagnosis of tumours |
09/04/1991 | EP0445078A1 New use of a monoclonal antibody |
09/04/1991 | EP0445073A1 Benzofurans |
09/04/1991 | EP0445021A2 Tris acyl-2",3",4'ethylidene-4",6"-beta-D-glucopyranosides, their production and use in the synthesis of ethylidene-4",6"-beta-D-glucopyranosides of epipodophyllotoxin |
09/04/1991 | EP0444560A1 Antibody specific for the tumor necrosis factor receptor |
09/04/1991 | EP0444208A1 Lipid a monosaccharide analog |
09/04/1991 | EP0444181A1 C-erbb-2 external domain: gp75 |
09/04/1991 | EP0444129A1 Human neutrophilic granulocyte end-stage maturation factor and its preparation and use |
09/04/1991 | EP0202276B1 Composition for the treatment of psoriasis |
09/04/1991 | CN1054250A 吲哚衍生物 Indole derivatives |
09/03/1991 | WO1991013166A1 Antibody constructs with enhanced binding affinity |
09/03/1991 | WO1991013090A1 Improved chimeric toxins |
09/03/1991 | US5045558 Aromatase inhibitors, prevention of estrogen biosynthesis, treatment of breast cancer |
09/03/1991 | US5045543 Treatment of cancer with high probability of metastasis |
09/03/1991 | US5045541 Immunodeficiency disorders |
09/03/1991 | US5045534 Daunorubicin Derivatives |
09/03/1991 | US5045530 Conprising a micelle or a vesicle of a cationic teniside based on a hydrophobic alkyl-substituted pyridinium compound and a hydrophobic drug; drug delivery; skin disorders |
09/03/1991 | US5045462 Basic protein called phospholipase A2 isolated from the venom of a snake of the family elapidae and its amino acid sequence |
09/03/1991 | US5045320 Large multivalent immunogen |
09/03/1991 | US5045316 Pharmaceutical compositions and their use |
09/03/1991 | CA2077348A1 Antibody constructs with enhanced binding affinity |
09/03/1991 | CA1288436C Phenylquinolinecarboxylic acids and derivatives as antitumor agents |
08/29/1991 | DE4104308A1 Therapeutische verwendung von somatostatinpeptiden Therapeutic use of somatostatinpeptiden |
08/29/1991 | DE4006269A1 Antibody which binds to tumour necrosis factor receptors |
08/28/1991 | EP0443957A2 New 17-spiro substituted steroid compounds, process for their preparation and intermediates of this process, their use as medicines and pharmaceutical preparations containing them |
08/28/1991 | EP0443891A1 Use of N-myristoyl-(S)-phenylalanine for the preparation of a medicament for the treatment of disorders by inhibiting the myristoylation |
08/28/1991 | EP0443599A2 Monoclonal antibodies specific for tumor-associated antigens, method for their preparation and their use |
08/28/1991 | EP0443569A2 Diamine derivatives and their use in oncology |
08/28/1991 | EP0443518A2 Pharmaceutical containing episialo complex carbohydrate |
08/28/1991 | EP0443471A1 2'-Deoxy-2'-methylidenecytidine dihydrate, methods for its production and compositions |
08/28/1991 | EP0443404A1 Peptide fragments and analogs of thrombospondin |
08/28/1991 | EP0442926A1 Polypeptides |
08/28/1991 | EP0442878A1 Derivatives of tryptophan as cck antagonists |
08/28/1991 | CN1013674B Process for the preparation of n-sulfamyl-3-(2-guanidino-thiazol-4-yl-methylthio)-propion-amidine |
08/28/1991 | CN1013673B Indenopyrimidine derivatives |
08/28/1991 | CA2036975A1 Benzofurans |
08/27/1991 | US5043482 New derivatives of 5,6,7,8-tetrahydro-1-naphthalenol, a process for their preparation and cosmetic and pharmaceutical compositions containing them |
08/27/1991 | US5043335 Enzyme inhibitors; cardiovascular and central nervous system disorders |
08/27/1991 | CA1288098C 4-(guanin-9-yl)butanals and their 3-oxa, 3-thia and 2-ene derivatives having antiviral and antitumor activity |
08/24/1991 | CA2036912A1 Diamine derivatives and their use in oncology |
08/23/1991 | CA2036847A1 Steroid products containing a spiro radical in position 17; process for preparing the same and intermediates for this process; their use as t erapeutic agents and |
08/23/1991 | CA2036093A1 Peptide fragments and analogs of thrombospondin |
08/22/1991 | WO1991012238A1 Side-chain-homologous vitamin d derivatives, process for producing them, pharmaceutical preparations containing these derivatives and their use as medicaments |
08/22/1991 | WO1991012015A1 Biologically active amphiphilic peptides and method of inhibiting growth of target cells, virus or virally-infected cell |
08/22/1991 | WO1991012011A1 Novel anti-tumoral agent derived from dextran |
08/22/1991 | CA2058637A1 Side-chain homologous vitamin d derivatives, process for their production, pharmaceutical preparations containing these derivatives and their use as pharmaceutical agents |
08/21/1991 | WO1991012801A1 Compositions containing green porphyrins to destroy malignant cells in mononuclear cell populations |
08/21/1991 | EP0442538A1 High purified protein, production and use thereof |
08/21/1991 | EP0442350A1 Medical preparation containing stigmasta-4-en-3-one and the use thereof |
08/21/1991 | EP0441882A1 Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides |
08/21/1991 | EP0441832A1 Composition and treatment with biologically active peptides and certain anions. |
08/20/1991 | WO1991012265A1 N-phenyl n-alkoxycarbonylalkyl glycinamides, preparation method and drugs containing them |
08/20/1991 | US5041648 Phenylhydrazones of β-ionone |
08/20/1991 | US5041639 Polysubstituted derivatives of naphtalene, their process of preparation and their application in the cosmetic and pharmaceutical fields |
08/20/1991 | US5041580 Novel binuclear platinum complex and antitumor agent comprising this complex as active ingredient |
08/20/1991 | US5041579 Platinum complexes and uses therewith |
08/20/1991 | US5041535 Antileukemic and immunostimulant peptides |
08/20/1991 | US5041441 Method of chemotherapy using 1-phenyl-2-decanoylamino-3-morpholino-1-propanol |
08/20/1991 | US5041426 Immune system enhancing 3-β-d-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and nucleotides |
08/20/1991 | US5041425 Antitumor agent |
08/20/1991 | US5041424 Epipodophyllotoxin glucoside 4'-phosphate derivatives |
08/20/1991 | US5041289 Method of purging residual tumor cells in vitro with lymphokine activated cytotoxic cells |
08/20/1991 | CA2069087A1 N-phenyl n-alcoxycarbonylalkylglycinamides, their preparation and medicaments containing them |
08/20/1991 | CA2036365A1 Pharmaceutical containing episialo complex carbohydrate |
08/17/1991 | WO1991012250A1 Novel antiviral and antitumor terpene hydroquinones and methods of use |
08/17/1991 | CA2075942A1 Antiviral and antitumor terpene hydroquinones and methods of use |
08/14/1991 | WO1991012006A2 Tumor cell sensitization method |
08/14/1991 | EP0441467A1 Side chain homologes of vitamin D derivatives, process for their preparation, pharmaceutical compositions containing them and their use as medicines |
08/14/1991 | EP0441278A1 Polysaccharides with immunomodulating properties from astragalus membranaceus and pharmaceutical compositions containing them |
08/14/1991 | EP0441218A2 Anthracycline-glycosyl prodrugs, process for their preparation and their use in combination with functionalised tumour-specific enzyme conjugates |
08/14/1991 | EP0440744A1 Products and methods for controlling the suppression of the neoplastic phenotype |
08/14/1991 | EP0440731A1 2-aminocarboxylic acid derivatives, their manufacture and use as drugs |
08/14/1991 | CN1013491B Fluorinated diaminoalkyne derivs |
08/14/1991 | CA2076032A1 Tumor cell sensitization method |
08/13/1991 | US5039710 Viricides, antitumor agents |
08/13/1991 | US5039705 Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof |
08/13/1991 | US5039700 Cardiovascular disorders, antitumor agents |
08/13/1991 | US5039662 Pentapeptide containing tyrosine, isoleucine, glycine serine, and arginine |
08/13/1991 | US5039529 Novel heparin derivatives |
08/13/1991 | US5039521 Immune cell proliferation inhibitors |
08/13/1991 | CA1287578C Anti-human ovarian cancer immunotoxins and methods of use thereof |
08/10/1991 | WO1991012261A1 17β-SUBSTITUTED-4-AZA-5α-ANDROSTAN-3-ONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION |
08/10/1991 | CA2049318A1 17.beta.-substituted-4-aza-5.alpha.-androstan-3-one derivatives and process for their preparation |
08/10/1991 | CA2035948A1 Polysaccharides with immunomodulating properties from astragalus membranaceus and pharmaceutical compositions containing them |
08/09/1991 | CA2035959A1 Peptide compositions and uses therefor |
08/08/1991 | WO1991011719A1 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
08/08/1991 | WO1991011465A1 Vaccines against cancer and infectious diseases |
08/08/1991 | WO1991011459A1 Extracellular form of the human fibroblast growth factor receptor |